| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 21.40× | 21.40× | 19.49× | 15.60× | 14.37× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.21× | 0.21× | 0.22× | 0.23× | 0.20× | ||
| −2.81× | −2.81× | −3.54× | −4.40× | −3.23× | ||
| −0.97× | −0.97× | −1.26× | −1.69× | −1.33× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 14.37 | 15.60 | 19.49 | 21.40 | 21.40 | |
| Asset Turnover | 0.20 | 0.23 | 0.22 | 0.21 | 0.21 | |
| Cash Conversion (CFO/Net Income) | -3.23 | -4.40 | -3.54 | -2.81 | -2.81 | |
| CFO/EBITDA | -1.33 | -1.69 | -1.26 | -0.97 | -0.97 |